Intelligence · Clinical Development
Pipeline search results
Programs matching “bgb-” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 59 pipeline programs matching "bgb-" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
BGB-16673
BEONE MEDICINES AUS PTY LTD
B-cell Malignancy
3 trials -
BGB-16673-104
BEONE MEDICINES AUS PTY LTD
Relapsed or Refractory B-Cell Malignancies
1 trial -
BGB-45035
BEONE MEDICINES AUS PTY LTD
Rheumatoid Arthritis
1 trial -
BGB-A317
The First People's Hospital of Lianyungang
Gastric Cancer
1 trial -
BGB-A445
BEONE MEDICINES AUS PTY LTD
Urothelial Carcinoma
1 trial -
OBINUTUZUMAB, Zanubrutinib
BeiGene
Relapsed/Refractory Follicular Lymphoma
1 trial -
Tislelizumab (BGB-A317)
BEONE MEDICINES AUS PTY LTD
MSI-H/dMMR Solid Tumors
1 trial -
BGB DXP593
BeiGene
Covid19
1 trial -
BGB-11417
BEONE MEDICINES AUS PTY LTD
Mature B-cell Malignancies
1 trial -
BGB-15025
BEONE MEDICINES AUS PTY LTD
Advanced Solid Tumor
1 trial -
BGB-16673
BEONE MEDICINES AUS PTY LTD
Healthy Volunteers
1 trial -
BGB-16673
BEONE MEDICINES AUS PTY LTD
Chronic Spontaneous Urticaria
1 trial -
BGB-21447
BEONE MEDICINES AUS PTY LTD
Hormone-receptor-positive Breast Cancer
1 trial -
BGB-21447
BEONE MEDICINES AUS PTY LTD
Relapsed Non-Hodgkin Lymphoma
1 trial -
BGB-21447-101
BeiGene
mature B-Cell malignancies
1 trial -
BGB-24714
BEONE MEDICINES AUS PTY LTD
Solid Tumor, Adult
1 trial -
BGB-26808
BEONE MEDICINES AUS PTY LTD
Advanced Solid Tumor
1 trial -
BGB-3227-101
BEONE MEDICINES AUS PTY LTD
Solid tumors
1 trial -
BGB-43395
BEONE MEDICINES AUS PTY LTD
Advanced Solid Tumor
1 trial -
BGB-43395-101
BEONE MEDICINES AUS PTY LTD
Advanced or metastatic solid tumors including hormone receptor positive (HR+), human epidermal growth factor 2 negative (HER2-) breast cancer
1 trial -
BGB-45035
BEONE MEDICINES AUS PTY LTD
Healthy Participants
1 trial -
BGB-53038
BEONE MEDICINES AUS PTY LTD
Metastatic Solid Tumors
1 trial -
BGB-53038-101
BEONE MEDICINES AUS PTY LTD
Advanced or Metastatic Solid Tumors with KRAS Mutations or Amplifications
1 trial -
BGB-58067
BEONE MEDICINES AUS PTY LTD
Healthy Volunteers
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.